Multinationals tipped to target Indian pharma firms
International pharmaceutical companies are eagerly eyeing firms that operate in countries with exciting domestic growth prospects, reflecting widespread changes in the health care industry. Two such deals drove regional M&A activity last week, but while debt remained buoyant, equity activity cooled. Asiamoney.com rounds up capital market activity across the region.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts